Literature DB >> 12904966

Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation.

Zafiris J Daskalakis1,2, Bruce K Christensen3, Robert Chen4, Paul B Fitzgerald5, Robert B Zipursky3, Shitij Kapur3.   

Abstract

Previous studies suggest that antipsychotic medications may alter cortical inhibition (CI). The current study was designed to determine if typical or atypical antipsychotics indeed alter CI in healthy subjects using three CI paradigms as measured with transcranial magnetic stimulation (TMS): short interval intracortical inhibition (SICI), cortical silent period (CSP) and transcallosal inhibition (TCI). CI was measured before, 6 and 24 h after being randomly assigned to receive a single dose of 2 mg haloperidol (n=8), 10 mg olanzapine (n=10) or placebo (n=9). There was no significant effect on any measure of CI at 6 and 24 h after receiving olanzapine, haloperidol or placebo. Moreover, no significant change in the motor threshold was observed across the three medication groups. Therefore, single administration of an antipsychotic has no effect on CI or resting motor threshold. Whether chronic, repeated administration of antipsychotics has effects on CI requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904966     DOI: 10.1007/s00213-003-1548-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Interactions between two different inhibitory systems in the human motor cortex.

Authors:  T D Sanger; R R Garg; R Chen
Journal:  J Physiol       Date:  2001-01-15       Impact factor: 5.182

2.  Direct demonstration of interhemispheric inhibition of the human motor cortex produced by transcranial magnetic stimulation.

Authors:  V Di Lazzaro; A Oliviero; P Profice; A Insola; P Mazzone; P Tonali; J C Rothwell
Journal:  Exp Brain Res       Date:  1999-02       Impact factor: 1.972

3.  Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol.

Authors:  A L Nordström; L Farde; C Halldin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 4.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

Authors:  G E Alexander; M D Crutcher; M R DeLong
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

5.  Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation.

Authors:  U Ziemann; D Bruns; W Paulus
Journal:  Neurosci Lett       Date:  1996-04-26       Impact factor: 3.046

6.  Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.

Authors:  U Ziemann; F Tergau; D Bruns; J Baudewig; W Paulus
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1997-12

7.  Interaction between intracortical inhibition and facilitation in human motor cortex.

Authors:  U Ziemann; J C Rothwell; M C Ridding
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

8.  Effects of phenytoin on cortical excitability in humans.

Authors:  R Chen; A Samii; M Caños; E M Wassermann; M Hallett
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

9.  Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.

Authors:  U Ziemann; S Lönnecker; B J Steinhoff; W Paulus
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

10.  Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex.

Authors:  J F Smiley; S M Williams; K Szigeti; P S Goldman-Rakic
Journal:  J Comp Neurol       Date:  1992-07-15       Impact factor: 3.215

View more
  11 in total

Review 1.  [Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation].

Authors:  T Wobrock; D Kadovic; P Falkai
Journal:  Nervenarzt       Date:  2007-07       Impact factor: 1.214

2.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

Review 3.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

4.  Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans.

Authors:  V Di Lazzaro; A Oliviero; E Saturno; M Dileone; F Pilato; R Nardone; F Ranieri; G Musumeci; T Fiorilla; P Tonali
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

Review 5.  Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia.

Authors:  Shawn M McClintock; Catarina Freitas; Lindsay Oberman; Sarah H Lisanby; Alvaro Pascual-Leone
Journal:  Biol Psychiatry       Date:  2011-05-14       Impact factor: 13.382

6.  Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.

Authors:  Thomas Wobrock; Alkomiet Hasan; Berend Malchow; Claus Wolff-Menzler; Birgit Guse; Nicolas Lang; Thomas Schneider-Axmann; Ullrich K H Ecker; Peter Falkai
Journal:  Psychopharmacology (Berl)       Date:  2009-12-09       Impact factor: 4.530

7.  Modulation of human motor cortex excitability by quetiapine.

Authors:  Berthold Langguth; Peter Eichhammer; Claus Spranz; Michael Landgrebe; Ulrich Frick; Philipp Sand; Göran Hajak
Journal:  Psychopharmacology (Berl)       Date:  2007-11-23       Impact factor: 4.530

8.  Abnormal bihemispheric responses in schizophrenia patients following cathodal transcranial direct stimulation.

Authors:  Alkomiet Hasan; Richard Aborowa; Michael A Nitsche; Louise Marshall; Andrea Schmitt; Oliver Gruber; Peter Falkai; Thomas Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-02-09       Impact factor: 5.270

9.  Different patterns of cortical excitability in major depression and vascular depression: a transcranial magnetic stimulation study.

Authors:  Carmen Concerto; Giuseppe Lanza; Mariagiovanna Cantone; Manuela Pennisi; Daniela Giordano; Concetto Spampinato; Riccardo Ricceri; Giovanni Pennisi; Eugenio Aguglia; Rita Bella
Journal:  BMC Psychiatry       Date:  2013-11-09       Impact factor: 3.630

Review 10.  Transcranial magnetic stimulation (TMS) for schizophrenia.

Authors:  Nadine Dougall; Nicola Maayan; Karla Soares-Weiser; Lisa M McDermott; Andrew McIntosh
Journal:  Cochrane Database Syst Rev       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.